FAHFAs are detected in postprandial chylomicron and VLDL fractions and can be released from TG estolides by LPL in vitro

Dovilė Milonaitytė

doi:10.1016/j.jlr.2026.101059

Cardiac Magnetic Resonance Imaging Parameters Predict New-Onset Symptoms of Heart Failure in Hypertrophic Cardiomyopathy

2026-06-09

0

OA

AI

D

Danuzia S da Silva, MD, MPH

V

Vanessa Karlinski Vizentin, MD

I

Iuri Ferreira Felix, MD

M

Maren Maanja, MD, PhD

S

Simmy A Lahori, MBBS

K

Kalyan S Pasupathy, PhD

S

Steve Ommen, MD

J

Jeffrey B Geske, MD

J

John R Giudicessi, MD, PhD

P

Philip A Araoz, MD

M

Michael J Ackerman, MD, PhD

A

Adelaide M Arruda-Olson, MD, PhD

J

J Martijn Bos, MD, PhD *

DOI：10.1093/eschf/xvag160

Original

Original request for help

Save

Abstract

En 中文

Hypertrophic cardiomyopathy (HCM) is a heritable cardiac disorder characterized by increased left ventricular (LV) wall thickness, often leading to heart failure (HF). HF represents a significant burden and is a challenging condition to diagnose in individuals with HCM. Cardiovascular magnetic resonance (CMR) imaging provides detailed insights into cardiac assessment, but its role in predicting new onset of HF symptoms in patients with HCM remains unknown. This study aimed to identify CMR predictors associated with the development of HF symptoms in individuals with HCM.

Cardiac Magnetic Resonance Imaging Parameters Predict New-Onset Symptoms of Heart Failure in Hypertrophic Cardiomyopathy

Abstract

Journal

Organization

Cited Papers

Citing Papers